Literature DB >> 15047161

The interaction between apolipoprotein serum amyloid A and high-density lipoprotein.

Limin Wang1, Wilfredo Colón.   

Abstract

Serum amyloid A (SAA) is a small apolipoprotein that binds to high-density lipoproteins (HDLs) via its N-terminus. The murine isoform SAA2.2 forms a hexamer in solution and the N-terminus is shielded from the solvent. Therefore, it is unclear how the SAA2.2 hexamer might bind HDL. In this study, the binding of SAA2.2 to murine HDL was investigated by glutaraldehyde cross-linking and polyacrylamide gel electrophoresis. The hexamer did not bind HDL significantly at 20 degrees C. However, at temperatures between 25-30 degrees C, SAA2.2 became destabilized and its monomeric form bound to HDL. SAA2.2 binding did not significantly replace Apo A-I in HDL particles. At 37-45 degrees C SAA2.2 binds less to HDL, suggesting that its binding is weak and sensitive to physiological and pathological temperatures, and thereby, potentially modulated, in vivo, by other factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047161     DOI: 10.1016/j.bbrc.2004.03.027

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks.

Authors:  Nicholas M Frame; Olga Gursky
Journal:  FEBS Lett       Date:  2016-03-06       Impact factor: 4.124

2.  Structural Basis for Lipid Binding and Function by an Evolutionarily Conserved Protein, Serum Amyloid A.

Authors:  Nicholas M Frame; Meera Kumanan; Thomas E Wales; Asanga Bandara; Marcus Fändrich; John E Straub; John R Engen; Olga Gursky
Journal:  J Mol Biol       Date:  2020-02-06       Impact factor: 5.469

3.  Urea-induced denaturation of apolipoprotein serum amyloid A reveals marginal stability of hexamer.

Authors:  Limin Wang; Wilfredo Colón
Journal:  Protein Sci       Date:  2005-06-03       Impact factor: 6.725

4.  Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a "molecular mop" in immune response.

Authors:  Nicholas M Frame; Shobini Jayaraman; Donald L Gantz; Olga Gursky
Journal:  J Struct Biol       Date:  2017-06-20       Impact factor: 2.867

5.  Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.

Authors:  Saipraveen Srinivasan; Sanket Patke; Yun Wang; Zhuqiu Ye; Jeffrey Litt; Sunit K Srivastava; Maria M Lopez; Dmitry Kurouski; Igor K Lednev; Ravi S Kane; Wilfredo Colón
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

6.  Cleavage, Downregulation, and Aggregation of Serum Amyloid A.

Authors:  Wenhua Wang; Prabir Khatua; Ulrich H E Hansmann
Journal:  J Phys Chem B       Date:  2020-01-30       Impact factor: 2.991

7.  Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis.

Authors:  Jinghua Lu; Yadong Yu; Iowis Zhu; Yifan Cheng; Peter D Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

8.  Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study.

Authors:  Cara L Carty; Patrick Heagerty; Susan R Heckbert; Daniel A Enquobahrie; Gail P Jarvik; Scott Davis; Russell P Tracy; Alexander P Reiner
Journal:  J Atheroscler Thromb       Date:  2009-09-03       Impact factor: 4.928

Review 9.  The turning away of serum amyloid A biological activities and receptor usage.

Authors:  Sara Abouelasrar Salama; Mieke Gouwy; Jo Van Damme; Sofie Struyf
Journal:  Immunology       Date:  2021-01-04       Impact factor: 7.215

10.  Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease.

Authors:  June-Yong Lee; Jason A Hall; Lina Kroehling; Lin Wu; Tariq Najar; Henry H Nguyen; Woan-Yu Lin; Stephen T Yeung; Hernandez Moura Silva; Dayi Li; Ashley Hine; P'ng Loke; David Hudesman; Jerome C Martin; Ephraim Kenigsberg; Miriam Merad; Kamal M Khanna; Dan R Littman
Journal:  Cell       Date:  2019-12-19       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.